Silo Pharma, Inc. (SILO) News
Track canonical SquawkNews coverage tagged to SILO, Silo Pharma, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 8 indexed stories across 8 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Silo Pharma Acquires Software and IP From Norsight; Issues Warrant
Silo Pharma entered into an asset purchase agreement to acquire software, technology, and related intellectual property from Norsight. As consideration, the company issued a warrant to purchase up to 300,000 shares at $1
EQUITY | Oct 02, 2026, 08:43 PM UTC
L
SILO - Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio
SILO - Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio
NEWS | Sep 18, 2026, 12:50 PM UTC
L
SILO - Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum
SILO - Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum
EQUITY | Sep 09, 2026, 01:15 PM UTC
L
Silo Pharma gets notice of allowance for Canadian PTSD patent application
Silo Pharma (SILO) received a notice of allowance for a Canadian patent application covering a novel PTSD treatment, per the TradeXchange Newsdesk alert.
REGULATION | Aug 18, 2026, 08:15 PM UTC
M
Silo Pharma Subsidiary Collaborates with Caylent
Silo Pharma subsidiary partners with Caylent
EQUITY | Aug 06, 2026, 12:50 PM UTC
L
SILO Silo Pharma files to sell 1.91M shares of common stock for holders
SILO Silo Pharma files to sell 1.91M shares of common stock for holders
EQUITY | Jul 24, 2026, 08:07 PM UTC
L
SILO AMD Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform Access to AMD Developer Cloud credi
SILO AMD Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform Access to AMD Developer Cloud credits, AI development Tools and technical resources to support next-generation ente
EQUITY | Jul 14, 2026, 12:58 PM UTC
M
SILO: Reports Positive Data
Silo Pharma reports positive stability data for SPC-15 PTSD treatment, advancing program toward first-in-human clinical trial
EARNINGS | Jun 23, 2026, 12:23 PM UTC